CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease
Nature Communications2012Vol. 3(1), pp. 1146–1146
Citations Over TimeTop 10% of 2012 papers
Soosung Kang, Garry Cooper, Sara F. Dunne, Brendon Dusel, Chi-Hao Luan, D. James Surmeier, Richard B. Silverman
Related Papers
- → Role of voltage-gated calcium channels in epilepsy(2009)173 cited
- → L-Type Calcium Channels Contribute to the Tottering Mouse Dystonic Episodes(1999)122 cited
- → T-type calcium channel blockers as neuroprotective agents(2014)78 cited
- → Calcium buffers and L-type calcium channels as modulators of cardiac subcellular alternans(2019)1 cited
- N-type voltage-dependent calcium channel blockers on analgesia:research advances(2012)